Mark Morris
Cited by
Cited by
Germline SDHB mutations and familial renal cell carcinoma
C Ricketts, ER Woodward, P Killick, MR Morris, D Astuti, F Latif, ER Maher
Journal of the National Cancer Institute 100 (17), 1260-1262, 2008
Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility
D Astuti, MR Morris, WN Cooper, RHJ Staals, NC Wake, GA Fews, H Gill, ...
Nature genetics 44 (3), 277-284, 2012
Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma
MR Morris, CJ Ricketts, D Gentle, F McRonald, N Carli, H Khalili, M Brown, ...
Oncogene 30 (12), 1390-1401, 2011
Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma
MR Morris, C Ricketts, D Gentle, M Abdulrahman, N Clarke, M Brown, ...
Oncogene 29 (14), 2104-2117, 2010
Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a …
M Zatyka, NF da Silva, SC Clifford, MR Morris, MS Wiesener, KU Eckardt, ...
Cancer research 62 (13), 3803-3811, 2002
Mutations in SLC29A3, Encoding an Equilibrative Nucleoside Transporter ENT3, Cause a Familial Histiocytosis Syndrome (Faisalabad Histiocytosis) and Familial …
NV Morgan, MR Morris, H Cangul, D Gleeson, A Straatman-Iwanowska, ...
PLoS genetics 6 (2), e1000833, 2010
Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma
MR Morris, D Gentle, M Abdulrahman, EN Maina, K Gupta, RE Banks, ...
Cancer research 65 (11), 4598-4606, 2005
Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma
MR Morris, LB Hesson, KJ Wagner, NV Morgan, D Astuti, RD Lees, ...
Oncogene 22 (43), 6794-6801, 2003
Evidence for a Telomere-Independent “Clock” Limiting RAS Oncogene-Driven Proliferation of Human Thyroid Epithelial Cells
CJ Jones, D Kipling, M Morris, P Hepburn, J Skinner, A Bounacer, ...
Molecular and cellular biology 20 (15), 5690-5699, 2000
The epigenetic landscape of renal cancer
MR Morris, F Latif
Nature Reviews Nephrology 13 (1), 47-60, 2017
Bacillus subtilis natto: a non-toxic source of poly-γ-glutamic acid that could be used as a cryoprotectant for probiotic bacteria
AR Bhat, VU Irorere, T Bartlett, D Hill, G Kedia, MR Morris, ...
Amb Express 3 (1), 1-9, 2013
DNA methylation profiles of long-and short-term glioblastoma survivors
T Shinawi, VK Hill, D Krex, G Schackert, D Gentle, MR Morris, W Wei, ...
Epigenetics 8 (2), 149-156, 2013
CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma
FE McRonald, MR Morris, D Gentle, L Winchester, D Baban, J Ragoussis, ...
Molecular cancer 8 (1), 1-11, 2009
Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma
MR Morris, E Maina, NV Morgan, D Gentle, D Astuti, H Moch, T Kishida, ...
Journal of clinical pathology 57 (7), 706-711, 2004
The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain
RP Pangeni, P Channathodiyil, DS Huen, LW Eagles, BK Johal, D Pasha, ...
Clinical epigenetics 7 (1), 1-17, 2015
Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma
MR Morris, D Gentle, M Abdulrahman, N Clarke, M Brown, T Kishida, ...
British journal of cancer 98 (2), 496-501, 2008
Germline mutations in the CDKN2B tumor suppressor gene predispose to renal cell carcinoma
M Jafri, NC Wake, DB Ascher, DEV Pires, D Gentle, MR Morris, ...
Cancer discovery 5 (7), 723-729, 2015
Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics
MR Morris, ER Maher
Genome medicine 2 (9), 1-10, 2010
Familial non-VHL clear cell (conventional) renal cell carcinoma: clinical features, segregation analysis, and mutation analysis of FLCN
ER Woodward, C Ricketts, P Killick, S Gad, MR Morris, F Kavalier, ...
Clinical Cancer Research 14 (18), 5925-5930, 2008
Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma
CJ Ricketts, MR Morris, D Gentle, S Shuib, M Brown, N Clarke, W Wei, ...
Clinical epigenetics 5 (1), 1-14, 2013
The system can't perform the operation now. Try again later.
Articles 1–20